Jiangsu Jingye Pharmaceuticalinotungamirira mukupa 2-Amino-4′-Bromobenzophenone, musanganiswa wakafanana neutsva. Kuzivikanwa neCAS Nhamba 1140-17-6 uye inotsanangurwa neformula C13H10BrNO, iyi methanone inotorwa inopa mhando yepamusoro uye yemakwikwi mitengo, ichiratidza kuzvipira kwedu kune kugona mumakemikari emishonga.
Chimiro chemorekuru chekomboni iyi, ine boka rebromo pa 4 ′ chinzvimbo uye boka reamino pane 2 chinzvimbo pabenzophenone scaffold, inoiisa iyo yakasarudzika reactivity inoita kuti ive yakakosha muzvikamu zvakasiyana zveindasitiri yemakemikari. Chishandiso chayo chinotenderera kubva kumishonga kusvika pakati, APIs (Active Pharmaceutical Ingredients), tsika synthesis, uye zvakajairika makemikari.
Jiangsu Jingye Pharmaceuticalyakawana kucherechedzwa kwechigadzirwa ichi pasi peiyo yepamusoro banner inoti "Best Seller, High Quality, Competitive Price, Fast Delivery, Quick Response." Izvi zvinokudzwa chiratidzo chekuzvipira kwekambani kupa masevhisi epamusoro-soro uye zvigadzirwa kune vatengi vayo.
Zvishandiso zve2-Amino-4′-Bromobenzophenoneakawanda, achiwana basa rayo rakakosha seyepakati mukugadzirwa kwePronak. Seye organic synthesis yepakati uye yepakati yemishonga, komisheni iyi inoshanda sechinhu chakakosha chekuvaka mukutsvagisa marabhoritari nekusimudzira maitiro, pamwe neakakura-akawanda maitiro ekugadzira makemikari.
Uyezve, 2-Amino-4′-Bromobenzophenone ndeyechikamu chakabatana cheAromatic Benzophenones & Derivatives, kunyanya izvo zvinotsiviwa, izvo zvinowedzera zvingangoitika mukati meakasiyana makemikari mamiriro.
Mukupedzisa,2-Amino-4′-Bromobenzophenoneinomiririra ibwe rekona munharaunda yemakemikari emishonga, inopa nzira yakavimbika uye inobudirira yekugadzirwa kwemishonga inokosha uye masanganiswa. Iine Jiangsu Jingye Pharmaceutical pahelm, ichi chivakwa chinovimbisa mhando yepamusoro uye yemakwikwi mitengo, ichisimbisa chinzvimbo chayo sechinhu chakakosha kunharaunda yesainzi.Kana uchiida, unogonataura nesu: email:guml@depeichem.com/shiyf@depeichem.com.
Nguva yekutumira: Kubvumbi-24-2024